|
KDM2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.81440000000577E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.027400E-04 |
| Normal-vs-Stage2 |
8.874000E-02 |
| Normal-vs-Stage3 |
4.115600E-03 |
| Normal-vs-Stage4 |
6.275600E-03 |
| Stage1-vs-Stage2 |
4.805200E-01 |
| Stage1-vs-Stage3 |
7.228800E-01 |
| Stage1-vs-Stage4 |
9.026800E-01 |
| Stage2-vs-Stage3 |
4.232400E-01 |
| Stage2-vs-Stage4 |
6.135600E-01 |
| Stage3-vs-Stage4 |
6.950800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.13510000000628E-05 |
| Normal-vs-AfricanAmerican |
8.706300E-02 |
| Normal-vs-Asian |
3.443200E-03 |
| Caucasian-vs-AfricanAmerican |
4.437800E-01 |
| Caucasian-vs-Asian |
3.144600E-01 |
| AfricanAmerican-vs-Asian |
1.720220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.104900E-03 |
| Normal-vs-Female |
7.55249999984109E-07 |
| Male-vs-Female |
1.888020E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.272000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.7763000000024E-05 |
| Normal-vs-Age(61-80Yrs) |
2.878900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.529840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.015600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.488200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.336800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.965900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.063800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.437400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.32139999997616E-06 |
| Normal-vs-Grade 2 |
1.596990E-04 |
| Normal-vs-Grade 3 |
5.724500E-03 |
| Normal-vs-Grade 4 |
1.901450E-03 |
| Grade 1-vs-Grade 2 |
2.146300E-02 |
| Grade 1-vs-Grade 3 |
3.917700E-03 |
| Grade 1-vs-Grade 4 |
2.379800E-02 |
| Grade 2-vs-Grade 3 |
5.450000E-01 |
| Grade 2-vs-Grade 4 |
8.777600E-01 |
| Grade 3-vs-Grade 4 |
5.326200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.15140000001013E-06 |
| Normal-vs-ccB subtype |
9.280200E-03 |
| ccA subtype-vs-ccB subtype |
1.308580E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.177700E-04 |
| Normal-vs-N1 |
1.234160E-01 |
| N0-vs-N1 |
9.363200E-01 |
|
|
